Peter Kitz is vice-president, Global Pharmaceutical Quality, Bristol-Myers Squibb.
The GMP/GDP Inspection Landscape—Part I: Data
January 2nd 2017The European Federation of Pharmaceutical Industries and Associations (EFPIA) has conducted an annual survey of GMP/GDP inspections at sites and affiliates among its member companies from 2003 until the present time. This article describes findings of the EFPIA annual survey of site inspections among its member companies.